Data / Form D filings / LSC-BIO HC1, DST
LSC-BIO HC1, DST: Form D filings
LSC-BIO HC1, DST, a biotechnology company in Radnor, PA, filed 4 Form D notices with the SEC between 2017 and 2018. The latest, on March 2, 2018, reports $4.5 million sold of a $4.5 million offering to 12 investors.
Find out what LSC-BIO HC1, DST does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 595 EAST LANCASTER AVENUE, SUITE 300, Radnor, PA, 19087
- Phone
- (855) 434-2233
- Industry
- Biotechnology
- Entity type
- Business Trust
- Incorporated in
- Delaware
- Year incorporated
- 2017
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1725079
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2018 | Amendment | $4,453,890 | $4,453,890 | $0 | 12 | Nov 29, 2017 | sec.gov |
| Feb 23, 2018 | Amendment | $4,453,890 | $4,083,610 | $370,280 | 11 | Nov 29, 2017 | sec.gov |
| Dec 26, 2017 | Amendment | $4,453,890 | $3,561,610 | $892,280 | 7 | Nov 29, 2017 | sec.gov |
| Dec 13, 2017 | New notice | $4,453,890 | $2,603,701 | $1,850,189 | 3 | Nov 29, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| - Livingston Capital, LLC | Promoter | |
| Pietro Scola | Executive Officer |
Other biotechnology companies in Pennsylvania that filed recently
- Traws Pharma, Inc. offering · Nov 5, 2026
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
- Merlin Biotech, Inc. $50,000 · Aug 11, 2026
Every Form D from the week of Feb 26, 2018 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what LSC-BIO HC1, DST reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.